MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,102,000 | -43.7% | 18,280 | -57.0% | 0.02% | -43.2% |
| Q1 2016 | $1,957,000 | +134.4% | 42,554 | +146.3% | 0.04% | +131.2% |
| Q4 2015 | $835,000 | +22.3% | 17,280 | +7.5% | 0.02% | +14.3% |
| Q3 2015 | $683,000 | -60.2% | 16,080 | +6.9% | 0.01% | -56.2% |
| Q2 2015 | $1,718,000 | -11.5% | 15,040 | 0.0% | 0.03% | -8.6% |
| Q1 2015 | $1,941,000 | +30.5% | 15,040 | 0.0% | 0.04% | +34.6% |
| Q4 2014 | $1,487,000 | +50.4% | 15,040 | +50.4% | 0.03% | +52.9% |
| Q3 2014 | $989,000 | -14.4% | 10,000 | -33.3% | 0.02% | -19.0% |
| Q2 2014 | $1,156,000 | +43.6% | 15,000 | +20.0% | 0.02% | +40.0% |
| Q1 2014 | $805,000 | +26.2% | 12,500 | +25.0% | 0.02% | +36.4% |
| Q4 2013 | $638,000 | +6.5% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $599,000 | +21.7% | 10,000 | 0.0% | 0.01% | +10.0% |
| Q2 2013 | $492,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |